Menactra Vaccine
By Menactra
Rx
1 Solution for Injection in a Vial

Composition
Meningococcal Vaccine (Group A, C, Y & W-135)(16mcg) + Diphtheria Toxoid(48mcg)

Manufacturer - Sanofi India Ltd
Sanofi House, CTS No.117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400072

Expires on or after
January, 2027

liver
There is limited information about how Menactra Vaccine affects individuals with liver disease. It is important to speak with your doctor for guidance regarding its use in such cases.

kidney
Limited information is available regarding Menactra Vaccine use in patients with kidney disease. Please consult your doctor for advice.

alcohol
It is not clear if it is safe to drink alcohol with the Menactra Vaccine. Seek advice from your doctor.

driving
When using Menactra Vaccine, it is unknown if it affects driving ability. Avoid driving if you have symptoms that impact focus and reaction time.

pregnancy
Menactra Vaccine may not be safe to use during pregnancy. Limited human studies suggest potential harm to the developing baby, as shown in animal studies. Your doctor will assess benefits and risks before recommending the vaccine. Please consult your doctor before considering Menactra Vaccine during pregnancy.

breastfeeding
Information on the safety of Menactra Vaccine during breastfeeding is not available. It is better to consult your doctor before using Menactra Vaccine.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹5700
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024